OraSure Technologies (NASDAQ: OSUR) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.


DENTSPLY SIRONA pays an annual dividend of $0.35 per share and has a dividend yield of 0.6%. OraSure Technologies does not pay a dividend. DENTSPLY SIRONA pays out -10.1% of its earnings in the form of a dividend.

Risk & Volatility

OraSure Technologies has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for OraSure Technologies and DENTSPLY SIRONA, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OraSure Technologies 0 0 5 0 3.00
DENTSPLY SIRONA 1 2 6 0 2.56

OraSure Technologies currently has a consensus price target of $17.25, indicating a potential downside of 18.94%. DENTSPLY SIRONA has a consensus price target of $65.63, indicating a potential upside of 6.97%. Given DENTSPLY SIRONA’s higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than OraSure Technologies.

Institutional & Insider Ownership

93.0% of OraSure Technologies shares are held by institutional investors. Comparatively, 93.9% of DENTSPLY SIRONA shares are held by institutional investors. 6.4% of OraSure Technologies shares are held by insiders. Comparatively, 2.0% of DENTSPLY SIRONA shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.


This table compares OraSure Technologies and DENTSPLY SIRONA’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OraSure Technologies 22.29% 15.64% 13.88%
DENTSPLY SIRONA -20.57% 7.24% 5.02%

Valuation and Earnings

This table compares OraSure Technologies and DENTSPLY SIRONA’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
OraSure Technologies $135.07 million 9.37 $23.92 million $0.54 39.41
DENTSPLY SIRONA $3.84 billion 3.67 $823.80 million ($3.47) -17.68

DENTSPLY SIRONA has higher revenue and earnings than OraSure Technologies. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.


OraSure Technologies beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

OraSure Technologies Company Profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.


DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.